throbber
The Journal of Immunology
`
`2453
`
`Reprinted with permission from Nature 256 (5517): 495– 497 (1975). Copyright © 1975 Macmillan Publishers Ltd.
`
`Nature Vol. 256 August 7 1975
`
`495
`(MOPC 21) is an JgGJ (K) which has been
`The protein sccreled
`Equal numbers of cells from each parental
`fully sequenced""·
`of fused cells
`cultures
`Continuous
`line were fused using inactivated
`Sendai virus• and samples
`contining 2 10' cells were grown in selective medium in
`specificity
`of predefined
`antibody
`secreting
`separate dishes. Four OUI or ICn dishes shO\\Cd growth in
`hybrid
`independent
`medium and these "ere taken as
`selective
`by means of
`of predefined spcciftc antibodies
`THE manufacture
`from single fusion events. The karyotype
`lines, probably derived
`interest. There
`permanent tissue culture cell lines is of general
`of the hybrid cells after 5 months in culture was just under the
`number of permanenl cultures of
`are at present a considerable
`sum of the 1wo parental lines (Table 1). Figure I shows the
`been used to
`procedures have
`and screening
`myeloma cells'·'
`(IEF) pattern of the secreted products
`of
`isoelectric focusing'°
`in some of them. This, hov.ever, is
`reveal antibody activity
`different lines. The hybrid cells (samples c-li in Fig. I) give a
`source of monoclonal antibodies of predefined
`not a satisfactory
`much more complex pattern than either parent (a and b) or a
`of a number of
`We describe here the derivation
`specificity.
`mixture of the parental lines (m). The important feature of the
`red blood
`tissue culture cell lines which secrete anti-sheep
`new pa11ern is the presence of exlra bands (Fig. I, arrows).
`cell (SRBC) antibodies. The cell lines are made by fusion of a
`These new bands, however, do not seem to be the result of
`mouse myeloma and mouse spleen cells from an immunised
`this is indicated by the lEF
`in primary structure;
`differences
`of the
`donor. To understand the expression and interactions
`separate the heavy
`pattern of the products after reduction to
`lines. fusion experiments between
`l g chains from the parental
`and light chains (Fig. IB). The IEF pattern of chains of the
`two known mouse myeloma lines were carried
`out.
`hybrid clones (Fig. IB, g) is equivalent
`to the sum of the IEF
`chain result� from the integrated
`Each immunoglobulin
`pattern (a and b) of chains of the parental clones with no
`of one of several V and C geues coding respectively
`expression
`evidence of extra products. We conclude 1hat, as previously
`only
`Each cell expresses
`and constant sections.
`for its variable
`shown with interspecies hybrids ... , new lg molecules arc
`revie"ed in
`exclusion;
`one of the two possible alleles (allelic
`ref. 3). When two antibody-producing
`produced as a result of mixed association betv.ecn heavy and
`cells are fused, the
`light chains from the two parems. This process is intracellular
`and although
`products of both parental lines are expressed'·',
`as a mixed cell population does not give rise to such hybrid
`the light and heavy chains of both parental lines are randomly
`(compare 111 and g, Fig. I A). The individual cells
`joined, no evidence of scrambling of V and C sections is
`molecules
`must
`This result shows
`be able to express both isotypes.
`therefore
`These results, obtained in an heterologous system
`observed'.
`of one isotypc and idiotype
`the expression
`that in hybrid cells
`cells of rat and mouse origin, have now been con­
`involvin,g
`firmed by fusing two myeloma cells of the same mouse strain,
`does no1 exclude the expression of another: both heavy chain
`
`Chains B
`
`H(Pl)f I H(P3)
`
`L(P3)
`
`L(Pl)
`
`. ' ' .
`--
`
`Fig. l Autoradiograph
`of labelled compo­
`nents secreted by the parental
`and hybrid cell
`lines analysed by IEF before (A) and after
`were incubated
`reduction {8). Cells
`in the
`and the supernatant
`presence of "C-lysine"
`applied on polyacrylamide slabs.
`A, pH range
`6.0 (bottom) to 8.0 (top) in 4 M urea. 8, pH
`range S.0 (bonom) to 9.0 (top) in 6 M urea;
`the supernatant was
`incubated for 20 min nt
`37 •c in the presence of 8 M urea, 1.5 M
`and 0.1 M potassium phos­
`mercap1oe1nanol
`phate pH 8.0 before being applied to the right
`from parental cell lines
`slab. Supcrna1an1s
`in: a, Pl Bui; b, P3-X67Ag8; and m, mixture
`of equal number of Pl Bui and P3-X67Ag8
`cells. Supernatants from two independently
`derhed hybrid lines are shown: c-f, four
`sub<:lones from Hy-3; g and h, 1wo subclones
`out"' using
`from Hy-B. Fusion was carried
`10' cells of each parental line and 4,000
`Sendai
`units inactivated
`haemagglu1ina1ion
`virus (Searle).
`Cells were divided into ten
`equal samples and gro\\ n separa1ely in
`s<:lttthe medium (HAT medium, ref. 6).
`Medium was changed every 3 d. Successful
`hybrid lines were obtained in four of the cul-
`Hy-B
`IEF pallerns.
`1ures, and all gave similar
`and Hy-3 were funher cloned in soft agar".
`L, Light; H, heavy.
`
`a b c d e mf m g b
`
`a /i b g t1
`
`and under­
`and provide the background for the derivation
`and y2a) and both V" and both VL regions
`·sotypes (yl
`hybrid lines in which one of
`standing of antibody-secreting
`markers for
`There are no allotypic
`are expressed.
`(idiotypes)
`the C" region 10 provide direct proof fortheexpression of both
`spleen cell.
`the parental cells is an antibody-producing
`parental C,. regions. But this is indjca1ed by the phenotypic
`Two myeloma cell lines of BALB/c origin "ere used. Pl Bui
`link between the V and C regions.
`is resistant
`does not gro" in
`to 5-bromo-2'-deoxyuridine',
`a myeloma protein,
`6) and secretes
`hybridi­
`medium (HAT, ref.
`different
`Figure l A shows that clones derived from
`selective
`Adj PCS, which is an lgG2A (K), (ref. I). Synihcsis is not
`of one line are indistin­
`and from subclones
`su1ion experiments
`The second
`balanced and free light chains arc also secreted.
`This has also been observed in other experiments
`guishable.
`is resistam to
`cell line, P3-X63Ag8, prepared from P3 cells•,
`(data 001 sho"n). Variants were, however, found in a survey of
`20 µg ml-1 8-azaguanine and <lOl.'S not grow in HAT medium.
`100 subclones. The difference is often associated
`with changes
`
`1 of 3
`
`BI Exhibit 1022
`
`

`

`2454
`
`496
`
`PILLARS OF IMMUNOLOGY
`
`Nature Vol. 256 August 7 1975
`Fig. 2 Isolation of an anti-SR BC antibody­
`secreting cell clone. Activity was revealed by
`SRBC. Direct plaques
`a halo of haemolysed
`given by: a, 6,000 hybrid cells Sp-1; b, clones
`grown in soft agar from an inoculum of 2,000
`Sp-I cells; c, recloning of one of the positive
`clones Sp-1/7; d, higher mag nification of a
`positive clone. Myeloma cells (107 P3-X67A
`gS) were fused to 108 spleen cells from an
`im munised BALB/c mouse. Mice
`were im­
`munised by intraperitoneal injection of 0.2 ml
`packed SRBC diluted I :JO, boosted after l
`
`month and the spleens collected 4 d later.
`After fusion,
`cells (Sp-I) were grown for 8 d
`in HAT medium, changed at 1-3 d intervals.
`Cells were then grown in Dulbecco modified
`Eagle's medium, supplemented
`for 2 weeks
`
`
`with hypoxanthine and thymidine. Forty days
`after fusion the presence of anti-SRBC act­
`ivity was revealed as shown in a. The ratio of
`plaque forming cells/total number of hybrid
`cells was 1/30. This hybrid cell population
`was cloned in soft agar (50% cloning ef­
`A modified plaque assay was used to
`ficiency).
`
`reveal positive clones shown in b-d as follows.
`When cell clones had reached a suitable size,
`conditions with
`
`they were overlaid in sterile
`2 ml 0.6% agarose in phosphate-buffered
`saline containing
`25 µI packed SRBC and
`0.2 ml fresh guinea pig serum (absorbe d with
`SRBC) as source of complement. b, Taken
`at 37 °C. The ratio
`
`after overnight incubation
`nwnber of clones was 1/33. A
`of positive/total
`suitable positive
`clone was picked out and
`This clone was called
`grown in suspension.
`Sp-1/7, and was recloned as shown inc; over
`
`
`90% of the clones gave positive Jysis. A second
`in which 10• P3-X67Ag8cells were
`experiment
`fused with 108 spleen cells was the source of
`a clone giving rise to indirect plaques (clone
`plaques were produced by
`
`Sp-2/3-3). Indirect
`the addition of I :20 sheep anti-MOPC 21
`antibody to the agarose overlay.
`
`in the ratios of the different chains and occasionally with the
`
`assays13 have been used to detect specific clones and representa­
`
`total' disappearance of one or other of the chains. Such events
`
`
`tive clones of both types have been characterised and studied.
`
`are best visualised on IEF analysis of the separated chains
`The derived lines (Sp hybrids) are hybrid cell lines for the
`(for example, Fig. !h, in which the heavy chain of P3 is no
`
`following reasons. They grow in selective medium. Their
`karyotype after 4 months in culture (Table I) is a little smaller
`
`longer observed). The important point that no new chains are
`detected by £EF complements a previous study• of a rat-mouse
`than the sum of the two parental lines but more than twice the
`hybrid line in which scrambling of V and C regions from the
`
`chromosome number of normal BALB/c cells, indicating that
`light chains of rat and mouse was not observed. �n this study,
`the lines are not the result of fusion between spleen cells. In
`both light chains have identical c. regions and therefore
`
`addition the lines contain a metacentric chromosome also
`scrambled VL-CL molecules would be undetected.
`On the other
`
`present in the parental P3-X67Ag8. Finally, the secreted
`MOPC 21 protein in addition to new,
`
`
`hand, the heavy chains are of different subclasses and we
`immunoglobulinscontain
`expect scrambled VH-CH to be detectable
`by IEF. They were
`unknown components. The latter presumably represent the
`not observed in the clones studied and if they occur must do
`chains derived from the specific anti-SRBC antibody. Figure 3A
`
`so at a lower frequency. We conclude that in syngeneic cell
`sh.ows the lEF pattern of the material secreted by two such
`cell hybrids) V-C integration
`hybrids (as well as in interspecies
`is
`Sp hybrid clones. The lEF bands derived from the parental P3
`
`
`not the result of cytoplasmic events. Integration as a result of
`line are visible in the pattern of the hybrid cells, although
`
`
`
`DNA translocation or rearrangement during transcription is
`obscured by the presence of a number of new bands. The
`
`also suggested by the presence of integrated mRNA molecules11
`pattern is very complex, but the complexity of hybrids of this
`and by the existence of defective heavy chains in which a
`
`
`type is likely to result from the random recombination of
`deletion of V and C sections seems to take place in already
`chains (see above, Fig. !). Indeed, lEF patterns of the reduced
`committed cells12•
`
`material secreted by the spleen-P3 hybrid clones gave a simpler
`The cell line P3-X63Ag8 described above dies when exposed
`pattern of lg chains. The heavy and light chains of the P3
`to HAT medium. Spleen cells from an immunised mouse also
`parental line became prominent, and new bands were apparent.
`die in growth medium. When both cells are fused by Sendai
`The hybrid Sp-I gave direct plaques and this suggested that
`it produces an IgM antibody. This is confirmed in Fig. 4 which
`virus and the resulting mixture is grown in HAT medium,
`
`surviving clones can be observed to grow and become estab­
`
`shows the inhibition of SRBC lysis by a specific anti-lgM
`lished after a few weeks. We have used SRBC as immunogen,
`
`which enabled us, after culturing the fused lines, to determine
`Table 1 Numbe r of chromosomes in parental and
`
`the presence of specific antibody-producing cells by a plaque
`hybrid cell lines
`
`assay techniquei3 (Fig. 2a). The hybrid cells were cloned in
`
`Mean Number of chromosomes per cell
`
`Cell line
`soft agar14 and clones producing antibody were easily detected
`65
`66,65,65,65,65
`P3-X67Ag8
`by an overlay of SRBC and complement (Fig. 2b). Individual
`55
`Pl Bui
`Ref. 4
`40
`clones were isolated and shown to retain their phenotype as
`Mouse spleen cells
`106
`Hy-B (Pl-P3)
`almost all the clones of the derived purified line are capable of
`90
`Sp-1/7-2
`lysing SRBC (Fig. 2c). The clones were visible to the naked
`95
`Sp-2/3-3
`eye (for example, Fig. 2d). Both direct and indirect plaque
`
`112,l 10.104,104,102
`93,90,89,89,87
`97 ,98,96,96,94,88
`
`2 of 3
`
`BI Exhibit 1022
`
`

`

`The Journal of Immunology
`
`Nature Vol. 256 August 7 1975
`
`2455
`
`497
`
`antibody. IEF techniques usually do not reveal J9S lgM
`
`
`
`
`
`molecules. 1gM is therefore unlikely to be present in the
`a (Fig. 38) but µ chains should contribute
`unreduced sample
`(sample a, Fig. 3A).
`
`to the pattern obtained after reduction
`
`
`The above results show that cell fusion techniques are a
`
`powerful tool to produce specific antibody directed against a
`
`
`
`predetermined antigen. II further shows that it is possible to
`
`
`isolate hybrid lines producing different antibodies directed
`
`
`
`against the same antigen and carrying different effector func­
`
`
`tions (direct and indirect plaque).
`
`The uncloned population of P3-spleen hybrid cells seems
`
`
`quite heterogeneous. Using suitable detection procedures it
`
`
`should be possible to isolate tissue culture cell lines making
`
`
`
`
`different classes of antibody. To facilitate our studies we have
`used a myeloma parental line which itself produced an lg.
`
`
`Variants in which one of the parental chains is no longer ex­
`pressed seem fairly common in the case of PJ-P3 hybrids
`(Fig. lh). Therefore
`
`selection of lines in which only the specific
`
`
`antibody chains are expressed seems reasonably simple.
`
`
`
`Alternatively, non-producing variants �f myeloma lines could
`be used for fusion.
`We used SRBC as antigen. Three different fusion experiments
`
`
`
`
`were successful in producing a large number of antibody­
`cells. Three weeks after the initial
`producing
`fusion, 33/1,086
`Fig. 4 Inhibition of haem olysis by antibody
`by hybrid
`secreted
`
`clone Sp-J/7-2. The reactioo was in a 9-cm Petri dish with a layer
`I /80
`of5 ml 0.6% agarose in phosphate-buffered
`saline containing
`2.5 µI 20 limes concentrated
`(v/v) SRBC. Cenire well contains
`and 2.5 µI mouse serum. a,
`
`culture medium of clone Sp-1/7-2
`Sheep specific anti-mouse macroglobulin (MOPC
`104E, Dr
`Feinstein); b, sheep anti-MO PC 21 (P3) lgGl absorbed with Adj
`PC-5 (lgG2a) absorbed with MOPC 21.
`PC-5; c, sheep anti-Adj
`
`After overnight incubation at room tem perature the plate was
`developed with guinea pig serum diluted I :10 in Dulbecco's
`
`mediwn without serum.
`
`A
`
`.B
`
`clones (3 %) were positive
`by the direct plaque assay. The
`was 50%. In another experi­
`
`cloning efficiency in the experiment
`
`
`ment, however, the proportion of positive clones was con­
`0.2 %). Jn a third experiment
`the hybrid
`
`siderably lower (about
`From 157
`
`population was studied by limiting dilution analysis.
`as many as 15 had anti-SRBC activity.
`independent hybrids,
`
`
`
`The proportion of positive over negative clones is remark­
`
`ably high. It is possible that spleen cells which have been
`
`
`
`
`triggered during immunisation are particularly successful in
`giving rise to viable hybrids.
`l t remains to be seen whether
`
`
`similar results can be obtained using other antigenes.
`
`The cells used in this study are all of BALB/c origin and the
`
`hybrid clones can be injected into BALB/c mice to produce
`
`solid tumours and serum having anii-SRBC activity. It is
`
`
`
`possible to hybridise antibody-producing cells from different
`
`origins•·•. Such cells can be grown i11 vitro in massive cultures
`
`
`to provide specific antibody. Such cultures could be valuable
`
`for medical and industrial use.
`
`M RC Laboratory of Molecular Biology,
`Hills Road, Cambridge C82 2QH. UK
`
`G. KOHLER
`C. MtLSTEIN
`
`J
`
`,.
`
`·.
`
`c a
`
`c b
`
`Received May 14; accepted June 26, J97S.
`I Polter. M .• Phy.,iol. R
`..... 52. 631-719 (1972).
`1 Horibata, K., :tnd Harris.
`A. w .. Exp( Cell RPS., 60, 61-70 (1970).
`J Milstein. C .. and Munro, A. J .• in D'rfence and Recognition
`(edit. by Porte!', R. R.),
`199·228 tMTP Int. Rev. Sci., Bu1tcrnorth, London, 1973).
`•Colton, R. O. H., and Milstein. C., Nature. 244, 42-43 (1973).
`5 Schwabcr, J., and Cohen. E. P •• Proc. 11arn. Ac11d.Sci. U.S.A .• 71, 2203-2207(1974).
`• Lilllcfield. J. w .. Srienc•, 145, 709 (1964).
`7 Svas1i, J .. and Milsiein, C., Biocliem. J .• 128, 427-444 {1972).
`Adctu"bo, K., Cowan. N. J .. and Sc<:bcr, 0. S., Pro1urss in lmmunu·
`! Milstein. C.,
`logy, II, I (edit. by
`Bren1, L., and Holborow. J.). 157-168 (North-Holland.
`Amsterdam,
`1974).
`Fig. 3 Auioradiograph
`by anti­
`of labelled components secreted
`
`
`•Harris. H .. and Wa1kin•. J. F .. N"'""· 205, 640-646 (1965).
`10 Awdch, A. L .. Williamson. A. R., and Askonas, B. A .. Nature. 219, 66-67 0968).
`after(A)
`SR BC specific hybrid lines. Fractionation
`bcfore(B)and
`E. M .. Jar\'Js, J.M., and Proudfoo1,
`11 Milstein, C .. Brownlee. G. G .. Cartwright,
`was by IEF. pH gradient was 5.0 (bollom)
`to 9.0 (top)
`reduction
`N. J., Nature, 252. 354-359 (1974\.
`in the presence of 6 M urea. Other conditions as in Fig. I. Supcr­
`11 Frongione, B., and Milstein, C., Naftlrc, 244, 597-599 (1969).
`b, hybrid clone Sp-2/3-3;
`IJ Je1 ne, N. K .. and Nordin. A. A .• Sc/Pnc'e.
`140. 405 (1963;.
`a, hybrid clone Sp-1/7-2;
`natants from:
`14 Conon. R. G. H .. Secher, 0. S., and Milstein,
`C., Eur. J. lmmun., 3, 135-140
`c, myeloma line P3-X67Ag8.
`t 1973).
`
`c
`
`a c
`
`c
`
`3 of 3
`
`BI Exhibit 1022
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket